A01K 67/027
New or modified breeds of vertebrates
A01K67/027 (New or modified breeds of vertebrates) appears on 4,045 US grants and 6,951 published applications in this corpus.
Search patents in A01K- Granted patents
- 4,045
- Published applications
- 6,951
- Assignees
- 2,200
- Inventors
- 11,199
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 9 | 0 |
| 1993 | 3 | 0 |
| 1994 | 10 | 0 |
| 1995 | 16 | 0 |
| 1996 | 51 | 0 |
| 1997 | 88 | 0 |
| 1998 | 124 | 0 |
| 1999 | 116 | 0 |
| 2000 | 111 | 0 |
| 2001 | 135 | 44 |
| 2002 | 104 | 290 |
| 2003 | 123 | 357 |
| 2004 | 97 | 300 |
| 2005 | 78 | 310 |
| 2006 | 130 | 355 |
| 2007 | 122 | 267 |
| 2008 | 105 | 262 |
| 2009 | 124 | 271 |
| 2010 | 142 | 286 |
| 2011 | 114 | 284 |
| 2012 | 119 | 225 |
| 2013 | 137 | 234 |
| 2014 | 127 | 271 |
| 2015 | 154 | 280 |
| 2016 | 155 | 276 |
| 2017 | 163 | 284 |
| 2018 | 158 | 286 |
| 2019 | 180 | 355 |
| 2020 | 190 | 315 |
| 2021 | 174 | 289 |
| 2022 | 150 | 273 |
| 2023 | 158 | 213 |
| 2024 | 144 | 252 |
| 2025 | 131 | 217 |
| 2026 | 94 | 155 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Non-human animals having humanized Fc-gamma receptors29 Sep 2026US 12,745,761 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified non-human animal with human or chimeric TFR122 Sep 2026US 12,740,550 B2Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene22 Sep 2026US 12,742,179 B2National Jewish Health
- Method for producing genetically edited birds having resistance to avian influenza viruses22 Sep 2026US 12,742,180 B2Seoul National University R&Db Foundation
- Non-canonical SWI/SNF complex and uses thereof8 Sep 2026US 12,729,225 B2Dana-Farber Cancer Institute, Inc.
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Genetically Modified Non-Human Animals and Methods of Use Thereof8 Oct 2026US 2026/0305588 A1Institute for Research in Biomedicine (IRB)
- Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse8 Oct 2026US 2026/0308532 A1Fred Hutchinson Cancer Center
- Mouse model with humanized telomere1 Oct 2026US 2026/0293864 A1Washington State Univesity
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Production of antibodies from transgenic animals1,567US 5,545,807 AMedical Research Council · 1996